[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![Quantumup1 Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1060595604022280192.png) quantumup [@Quantumup1](/creator/twitter/Quantumup1) on x 3533 followers
Created: 2025-07-02 11:59:04 UTC

Citizens reiterated $MDGL Market Outperform-$470.
$AKRO $IVA $VKTX $ALGS $LLY $ETNB $SGMT #EASL
Citizens said in its note to investors:
"Madrigal ( $MDGL, MO, $XXX PT) will deliver a podium presentation highlighting a comparative meta-analysis of glucagon receptor agonists vs. Rezdiffra in #MASLD and #MASH during the "The Evolving Landscape of MASLD: From Pathophysiology to Therapeutic Innovations" session on Saturday, July XX. Rezdiffra will be highlighted in two posters, which will discuss meta-analyses comparing its efficacy to AkeroanIs ( $AKRO, NC) FGF21 efruxifermin, along with a systemic review of Rezdiffra's randomized controlled trials.

The U.S. Rezdiffra launch continues to exceed expectations, with >17K patients on drug as of last quarter and sales handily beating consensus (our coverage here).

$MDGL is also gearing up for its EU launch, with a regulatory decision anticipated in August. Data recently presented at #EASL for Rezdiffra and efruxifermin in compensated cirrhotics showed
promise (our coverage here), and we look forward to the comparative analysis in #MASH."


XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1940379694144028958/c:line.svg)

**Related Topics**
[$sgmt](/topic/$sgmt)
[$etnb](/topic/$etnb)
[$lly](/topic/$lly)
[$algs](/topic/$algs)
[$iva](/topic/$iva)
[$akro](/topic/$akro)
[$mdgl](/topic/$mdgl)
[$vktx](/topic/$vktx)

[Post Link](https://x.com/Quantumup1/status/1940379694144028958)